Clinical Trials on Autoimmune Retinopathy in United Kingdom

Total 5448 results

National Eye Institute (NEI)

Completed

Rituximab for Autoimmune Retinopathy

Autoimmune Disease

United States
Manchester University NHS Foundation Trust

Withdrawn

Panretinal Photo-stimulation in Proliferative Diabetic Retinopathy (PRPhS)

Severe Non-proliferative Diabetic Retinopathy

United Kingdom
Moorfields Eye Hospital NHS Foundation Trust
Insulin Dependant Diabetes Trust

Completed

Retinal Laser by Multi-spot Photocoagulator and Driving Eligibility

Proliferative Diabetic Retinopathy

United Kingdom
Tameside General Hospital

Completed

Automated Screening of Diabetic Retinopathy Using a Smartphone-based Camera

Diabetic Retinopathy

United Kingdom
Moorfields Eye Hospital NHS Foundation Trust

Completed

UK Surveillance of Treated Retinopathy of Prematurity

Retinopathy of Prematurity

United Kingdom
NHS Lothian

Completed

Pain in Neonates During Screening for Retinopathy of Prematurity Using Two Methods (RETCAM)

Pain | Retinopathy of Prematurity

United Kingdom
University of Nottingham
University Hospitals of Derby and Burton NHS Foundation Trust

Completed

Feasibility of Nurse-led Retinal Imaging for Retinopathy of Prematurity Screening Employing the Optos California (N_ORS)

Retinopathy of Prematurity

United Kingdom
Bayer

Recruiting

An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)

Preterm Infants | Retinopathy of Prematurity

United Kingdom
Association for Innovation and Biomedical Research...
European Vision Institute Clinical Research Network

Completed

Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy. (PROTEUS)

High Risk Proliferative Diabetic Retinopathy

Portugal, Italy, United Kingdom, France
The Cleveland Clinic

Withdrawn

Steroids for Early Treatment of Radiation Retinopathy

Radiation Retinopathy

United States
The New York Eye Cancer Center
Genentech, Inc.

Completed

High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy

Radiation Retinopathy

United States
Washington University School of Medicine

Completed

Eye Patch Therapy for Central Serous Retinopathy (CSR)

Central Serous Retinopathy (CSR)

United States
Amy C Schefler, MD
Regeneron Pharmaceuticals

Unknown

Intravitreal Aflibercept Injection for Radiation Retinopathy Trial (ARRT)

Radiation Retinopathy

United States
Greater Houston Retina Research
Genentech, Inc.

Completed

Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. (RRR)

Radiation Retinopathy

United States
CSL Behring

Terminated

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CSL730 in Healthy Adult Subjects

Immune Complex-mediated Autoimmune Diseases

United Kingdom
Shire

Completed

Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP) (PEDAL)

Retinopathy of Prematurity (ROP)

United States, Italy, Netherlands, Poland, Sweden, United Kingdom
Retina Institute of Hawaii

Unknown

Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography (DIVER)

Diabetic Macular Edema | Proliferative Diabetic Retinopathy | Severe Nonproliferative Diabetic Retinopathy | Mild Nonproliferative Diabetic Retinopathy | Moderate Nonproliferative Diabetic Retinopathy

United States
Queen Margaret University

Recruiting

The Effects of FES in a Variety of Walking Conditions in People With MS

Multiple Sclerosis

United Kingdom
Sanofi

Completed

Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male Subjects

Multiple Sclerosis

United Kingdom
Takeda

Completed

A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants

Autoimmune Disease

United Kingdom
Queen Mary University of London

Completed

Oral Cladribine B-cell Study

Multiple Sclerosis

United Kingdom
GlaxoSmithKline

Completed

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants

Multiple Sclerosis

United Kingdom
University of Oxford
University of Edinburgh; National Institute for Health Research, United Kingdom and other collaborators

Completed

Lowering Events in Non-proliferative Retinopathy in Scotland (LENS)

Diabetic Retinopathy

United Kingdom
University of Edinburgh

Completed

Neuroretinal Biomarkers in Neurodegenerative Diseases

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Imperial College London

Completed

Stem Cells in Rapidly Evolving Active Multiple Sclerosis (STREAMS)

Multiple Sclerosis

United Kingdom
Queen Mary University of London
Novartis Pharmaceuticals; University College, London; Barts & The London NHS... and other collaborators

Completed

Protective Role of Oxcarbazepine in Multiple Sclerosis (PROXIMUS)

Multiple Sclerosis

United Kingdom
University of Nottingham

Completed

Providing Emotional Support Around the Point of Multiple Sclerosis Diagnosis: PrEliMS 2 (PrEliMS2)

Multiple Sclerosis

United Kingdom
Pipeline Therapeutics, Inc.

Completed

PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers

Multiple Sclerosis

United Kingdom
The Leeds Teaching Hospitals NHS Trust
University of Leeds

Completed

Kinematic Assessment In Multiple Sclerosis (KAIMS)

Multiple Sclerosis

United Kingdom
University of Nottingham
Swansea University; Multiple Sclerosis Society UK

Completed

The PrEliMS Feasibility Trial (PrEliMS)

Multiple Sclerosis

United Kingdom
University College, London
University College London Hospitals

Unknown

Regulation of Lipid Metabolism in Autoimmune Disease: Multiple Sclerosis (RELOAD-MS)

Multiple Sclerosis

United Kingdom
NHS Greater Glasgow and Clyde
University of Glasgow

Completed

Mindfulness-based Stress Reduction in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
University of Nottingham
University of Lincoln; MS Society

Recruiting

Who Benefits Most From Cognitive Rehabilitation for Multiple Sclerosis?

Multiple Sclerosis

United Kingdom
University of Lincoln
University of Nottingham; National University of Ireland, Maynooth; University... and other collaborators

Recruiting

Strengthening Mental Abilities With Relational Training (SMART) in Multiple Sclerosis (MS): A Feasibility Trial (SMART_MS)

Multiple Sclerosis

United Kingdom
Nottingham University Hospitals NHS Trust

Completed

DECISIve - DiagnosE Using the Central veIn SIgn v1.0 (DECISiVE)

Multiple Sclerosis

United Kingdom
Jazz Pharmaceuticals

Completed

An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients

Multiple Sclerosis

United Kingdom
Queen Mary University of London
Roche Pharma AG; Barts & The London NHS Trust

Completed

Under and Over Rehabilitation Study

Multiple Sclerosis

United Kingdom
Cardiff University

Completed

Life-Style Exercise and Activity Package for People Living With Progressive MS (LEAP-MS)

Multiple Sclerosis

United Kingdom
GlaxoSmithKline

Terminated

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
King's College London
National Multiple Sclerosis Society

Completed

Development and Evaluation of a New Palliative Care Service for People Severely Affected With Multiple Sclerosis (MS)

Multiple Sclerosis

United Kingdom
Bayer

Completed

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy, DR) (DeFineDR)

Diabetic Retinopathy

United Kingdom, Bulgaria
Queen Mary University of London

Recruiting

Famciclovir in Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Belfast Health and Social Care Trust
National Institute for Health Research, United Kingdom

Completed

Effectiveness of Multimodal Imaging for the Evaluation of Retinal Oedema And New vesseLs in Diabetic Retinopathy (EMERALD)

Diabetic Macular Edema | Proliferative Diabetic Retinopathy

United Kingdom
Moorfields Eye Hospital NHS Foundation Trust
Novartis

Completed

Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation (LUCIDATE)

Diabetic Retinopathy

United Kingdom
Jazz Pharmaceuticals

Completed

A Study to Evaluate the Efficacy of Sativex in Relieving Symptoms of Spasticity Due to Multiple Sclerosis

Multiple Sclerosis

United Kingdom
Hoffmann-La Roche

Completed

A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy (CANBERRA)

Diabetic Retinopathy

United States, United Kingdom, Spain, Poland, Slovakia, Australia, Puerto Rico
Jazz Pharmaceuticals

Completed

A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

Multiple Sclerosis | Spasticity

United Kingdom
GlaxoSmithKline

Terminated

A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

Multiple Sclerosis, Relapsing-Remitting

United Kingdom
University of Florida

Completed

Pediatric Type 1 Diabetes and Retinopathy

Diabetic Retinopathy

United States

Clinical Trials on Autoimmune Retinopathy in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations